Vanessa Milogiannakis

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis et al. · EBioMedicine · 2022 · 155 citations · Full text

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker et al. · 2021 · 71 citations · Full text

Monoclonal Antibody Therapies, Viral Diagnostics, Immunodeficiencies +23

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia

Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker et al. · Nature Microbiology · 2022 · 54 citations · Full text

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean et al. · EBioMedicine · 2023 · 54 citations · Full text

Viral Evolution, Antibody Breadth, Antibody Evasion +8

COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity

Yandong Shen, Jane A. Freeman, Juliette Holland et al. · British Journal of Haematology · 2021 · 45 citations

Clinical Immunology, Humoral Response, Immunology +21